Cathay Biotech (SH:688065)2021-10-28 16:00Financial Performance - The company's revenue for Q3 2021 reached ¥618,482,804.88, representing a 72.37% increase compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2021 was ¥163,579,471.31, reflecting a 42.41% year-over-year growth[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021 was ¥160,843,973.51, up 48.20% from the previous year[4] - Total operating revenue for the first three quarters of 2021 reached ¥1,632,762,881.49, a 41.7% increase from ¥1,152,256,813.76 in the same period of 2020[18] - Net profit for Q3 2021 was ¥513,093,100.82, compared to ¥321,294,746.83 in Q3 2020, representing a 59.7% increase[19] - Total comprehensive income for Q3 2021 was ¥513,223,102.73, compared to ¥321,528,559 in Q3 2020[20] Research and Development - Research and development expenses totaled ¥28,076,589.65 for Q3 2021, a significant increase of 198.94% year-over-year[5] - The proportion of R&D expenses to revenue for Q3 2021 was 4.54%, an increase of 1.92 percentage points compared to the same period last year[5] - Research and development expenses for the first three quarters of 2021 were ¥84,595,322.59, an increase from ¥51,342,329.11 in the same period of 2020[18] Assets and Liabilities - The total assets at the end of Q3 2021 amounted to ¥14,994,260,257.30, a 23.56% increase from the end of the previous year[5] - Total liabilities as of Q3 2021 amounted to ¥1,239,619,005.26, compared to ¥650,738,563.16 in the previous year, indicating a 90% increase[17] - The total equity attributable to shareholders at the end of Q3 2021 was ¥10,547,866,179.18, showing a slight increase of 1.57% from the previous year[5] - The company's non-current assets totaled RMB 4.01 billion, compared to RMB 3.69 billion in the previous year, which is an increase of about 8.4%[15] Cash Flow - The net cash flow from operating activities for the year-to-date period reached ¥433,459,895.36, a 63.96% increase compared to the previous year[5] - Cash inflow from operating activities for the first three quarters of 2021 was approximately CNY 1.77 billion, an increase from CNY 1.54 billion in the same period of 2020, representing a growth of about 14.7%[22] - Cash inflow from investment activities totaled CNY 3.84 billion, compared to CNY 2.51 billion in the previous year, marking a significant increase of approximately 52.7%[23] - Cash inflow from financing activities was CNY 2.54 billion, down from CNY 5.28 billion in the previous year, reflecting a decrease of approximately 52.0%[23] Inventory and Receivables - Accounts receivable increased to RMB 341.75 million, compared to RMB 188.10 million in the previous year, reflecting an increase of about 81.6%[14] - Inventory levels rose to RMB 900.81 million, up from RMB 775.10 million, marking an increase of approximately 16.1%[15] - The company reported a significant increase in other receivables, which rose to RMB 9.52 million from RMB 8.32 million, an increase of about 14.4%[15] Financing and Shareholder Information - The company has engaged in financing activities, with Shanxi Lu'an Mining Group participating in a total of 80,000 shares in the transfer and financing business[12] - There are no known related party transactions among the top 10 shareholders, ensuring transparency in ownership structure[12]